How do JAK2-inhibitors work in myelofibrosis: An alternative hypothesis
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference10 articles.
1. Hypothesis: how do jak2-inhibitors work in myelofibrosis;Mesa;Leuk Res,2009
2. Jak2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials;Pardanani;Leukemia,2008
3. A phase i study of TG101348, an orally bioavailable JAK-selective inhibitor, in patients with myelofibrosis;Pardanani;Blood,2008
4. The JAK inhibitor, INCB018424, demonstrates durable and marked clinical responses in primary myelofibrosis and post-polycythemia/essential thrombocythemia myelofibrosis;Verdstovsek;Blood,2008
5. Pathogenesis of myelofibrosis with myeloid metaplasia: lessons from mouse models of the disease;Vannucchi;Semin Oncol,2005
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis;Leukemia;2016-08-01
2. Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis;Cochrane Database of Systematic Reviews;2015-04-10
3. Mutations in tyrosine kinase and tyrosine phosphatase and their relevance to the target therapy in hematologic malignancies;Future Oncology;2015-02
4. JAK2 mutants (e.g., JAK2V617F) and their importance as drug targets in myeloproliferative neoplasms;JAK-STAT;2013-07-15
5. Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis;Cochrane Database of Systematic Reviews;2013-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3